Primary non-Hodgkin lymphoma of the humerus following traumatic injury: Case report

Hematological Oncology

Volumn 21, Issue 3, 2003, Pages 109-114

  Stemberga, V ^a   Dobi Babic R ^a   Bosnar, A ^a   Cuculic D ^a   Fuckar D ^a   Stifter S ^a   Kusec R ^b   Marusic Vrsalovic M ^b   Jonjić, Nives ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b Medical Faculty ^*

Author keywords

Bone lymphoma; Prognosis; Trauma related tumour

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD79A ANTIGEN; PROTEIN BCL 2;

ADULT; B CELL LYMPHOMA; B LYMPHOCYTE; BIOPSY; BONE CANCER; BONE INJURY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMERUS; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LAW SUIT; LYMPHOCYTE; MALE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SHOULDER INJURY; TRAFFIC ACCIDENT; TREATMENT PLANNING;

ACCIDENTS, TRAFFIC; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, CD3; ANTIGENS, CD79; B-LYMPHOCYTES; BIOPSY; BONE NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA, NON-HODGKIN; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN, B-CELL; WOUNDS, NONPENETRATING;

EID: 0142214851     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/hon.713     Document Type: Review

References (23)

1. Dorfman HD, Czerniak B. Immunohematopoietic tumors. In Bone Tumors. Mosby Inc.: St. Louis, MO, 1998; 679-687.
2. Unni KK. Malignant lymphoma of bone. In Dahlin's Bone Tumors, Unni KK (ed.). Lippincott-Raven Publisher: Philadelphia, PA, 1996; 237-248.
3. Shah SH, Muzaffar S, Soomro IN, Pervez S, Hasan SH. Clinico-morphological pattern and frequency of bone cancer. J Pak Med Assoc 1999; 49: 110-112.
4. Kinjo T, Satoh T. A case of malignant lymphoma in the skull after head injury associated with multiple bone tumors. No Shinkei Geka - Neurol Surg 1985; 13: 1191-1196.
5. Parker JR, Lopez-Terrada D, Gresik MV, Vogel H, Baumgartner JE, Finegold MJ. Neutrophil-rich anaplastic large cell lymphoma of the skull presenting after head trauma. Pediatr Dev Pathol 2001; 4: 397-401.
6. Tagawa M, Momita S, Irie J. Primary B cell lymphoma of the skull following head trauma; a case report. Rinsho Ketsueki - Japanese. J Clin Hematol 1987; 28: 589-593.
7. Ostrowski ML, Unni KK, Banks PM, et al. Malignant lymphoma of bone. Cancer 1986; 58: 2646-2655.
8. Blasius S, Edel G, Vestring T, et al. Non-Hodgkin's lymphoma with primary osseous manifestation, from the files of the bone tumor registry of Westphalia. Verh Dtsch Ges Pathol 1992; 76: 146-150.
9. Shannon JA, Bell DR, Levi JA, Wheeler HR, Boyle FM. Bone presentation of Non-Hodgkin's lymphoma: experience at the Royal North Shore Hospital, Sydney; highlighting primary bone lymphoma. Aust NZ J Med 1994; 24: 701-704.
10. Franczyk J, Samuels T, Rubenstein J, Srigley J, Morava-Protzner I. Skeletal lymphoma. Can Assoc Radiol J 1989; 40: 75-79.
11. Brisco MJ, Tan LW, Orsborn AM, Morley AA. Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B lymphocyte clones in a polyclonal population. Br J Haematol 1990; 75: 163-167.
12. Dosoretz DE, Raymond AK, Murphy GF, et al. Primary lymphoma of bone: the relationship of morphologic diversity to clinical behaviour. Cancer 1982; 50: 1009-1014.
13. Clayton F, Butler JJ, Ayala AG, Ro JY, Zornoza J. Non Hodgkin's lymphoma in bone. Pathologic and radiologic features with clinical correlates. Cancer 1987; 60: 2494-2501.
14. Fairbanks RK, Bonner JA, Inwards CY, et al. Treatment of stage IE primary lymphoma of bone. Int J Radiat Oncol Biol Phy 1994; 28: 363-372.
15. Tsujimoto Y, Ikegami N, Crose CM. Characterisation of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene 1987; 2: 3-7.
16. Gascoyne R. Prognostic factors in diffuse large B-cell lymphoma. Symposium 6. Rev Esp Patol 1999; 32: 305-310.
17. Leonichi L, Delvecchio MT, Barbini P, et al. Correlation between apoptotic and proliferative indices in malignant non Hodgkin's lymphomas. Am J Pathol 1993; 142: 755-763.
18. Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107-1115.
19. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. Bcl-2 protein is a topographically restricted in tissues by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-6965.
20. Delpla PA, Rouge D, Durroux R, Rouquette I, Arbus L. Soft tissue tumors following traumatic injury: two observations of interest for the medicolegal causality. Am J Forensic Med Pathol 1998; 19: 152-156.
21. Morioka T, Tashima T, Nishio S, Nishie E, Fukui M, Okamura T. Malignant lymphoma of the scalp at the site of a previous blunt trauma - report of two cases. Surg Neurol 1994; 42: 117-120.
22. Narasimhan P, Arora A, Hitti I, Glasberg S, Kanzer B. Rapidly progressive fatal cutaneous T cell lymphoma with a trauma-related presentation. Cutis 2000; 66: 195-198.
23. Choong PF, Gaustafson P, Wilen H, et al. Prognosis following recurrent soft-tissue sarcoma: a staging system based on primary and recurrent characteristics. Int J Cancer 1995; 60: 33-37.